ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
20
views
0
references
Top references
cited by
3
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,463
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Lessons learned from recent cardiovascular clinical trials: Part II.
Author(s):
R Califf
,
David L DeMets
Publication date:
2002-08-13
Journal:
Circulation
Keywords:
Bias (Epidemiology)
,
Cardiovascular Diseases
,
therapy
,
Clinical Trials Data Monitoring Committees
,
Clinical Trials as Topic
,
methods
,
standards
,
Communication
,
Ethics, Medical
,
Humans
,
National Institutes of Health (U.S.)
,
Outcome Assessment (Health Care)
,
Reproducibility of Results
,
Research Design
,
Sweden
,
United States
Read this article at
ScienceOpen
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Methods by AKJournals
Author and article information
Journal
PubMed ID::
12176964
ScienceOpen disciplines:
Chemistry
Keywords:
Bias (Epidemiology)
,
Cardiovascular Diseases
,
therapy
,
Clinical Trials Data Monitoring Committees
,
Clinical Trials as Topic
,
methods
,
standards
,
Communication
,
Ethics, Medical
,
Humans
,
National Institutes of Health (U.S.)
,
Outcome Assessment (Health Care)
,
Reproducibility of Results
,
Research Design
,
Sweden
,
United States
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Bias (Epidemiology)
,
Cardiovascular Diseases
,
therapy
,
Clinical Trials Data Monitoring Committees
,
Clinical Trials as Topic
,
methods
,
standards
,
Communication
,
Ethics, Medical
,
Humans
,
National Institutes of Health (U.S.)
,
Outcome Assessment (Health Care)
,
Reproducibility of Results
,
Research Design
,
Sweden
,
United States
Comments
Comment on this article
Sign in to comment
Similar content
1,463
Building Personalized Cancer Follow-up Care Pathways in the United States: Lessons Learned From Implementation in England, Northern Ireland, and Australia
Authors:
Catherine Alfano
,
Michael Jefford
,
Jane Maher
…
Which Lessons Are Learned? Best Practices and World Bank Rural Telecommunications Policy
Authors:
Christina COURTRIGHT
Integration of Extreme Programming and User-Centered Design: Lessons Learned
Authors:
Zahid Hussain
,
Harald Milchrahm
,
Sara Shahzad
…
See all similar
Cited by
3
The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned
Authors:
Mark Shapiro
,
Susan Silva
,
Scott Compton
…
A third trial oversight committee: Functions, benefits and issues
Authors:
J Athene Lane
,
Carrol Gamble
,
William Cragg
…
Protein kinases in cardiovascular diseases
Authors:
Jiawen Chen
,
Yafei Li
,
Chong Du
…
See all cited by